Home › Linfoma non Hodgkin › Utah › Salt Lake City
Studi clinici su Linfoma non Hodgkin a Salt Lake City, UT
13 studi su Linfoma non Hodgkin cercano partecipanti presso sedi a Salt Lake City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
In reclutamentoFase 1/2
- Intermountain Health, Canyons Region, LDS Hospital, Salt Lake City
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
In reclutamentoFase 2
- Intermountain Healthcare, Salt Lake City
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
In reclutamentoFase 1
- Intermountain Healthcare, Salt Lake City
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
In reclutamentoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
In reclutamentoFase 3
- Intermountain Healthcare, Salt Lake City
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
In reclutamentoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- University of Utah, Salt Lake City
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
In reclutamentoFase 1
- University of Utah, Salt Lake City
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
In reclutamentoFase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
In reclutamentoStudio osservazionale
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
In reclutamentoFase 1/2
- University of Utah, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Salt Lake City
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
In reclutamentoStudio osservazionale
- University of Utah Hospital, Salt Lake City
Studi su Linfoma non Hodgkin in altre città
- Houston, TX31 studi
- New York City, NY31 studi
- Boston, MA26 studi
- Nashville, TN21 studi
- Philadelphia, PA20 studi
- Baldwin Park, CA19 studi
- Washington, DC18 studi
- Milwaukee, WI18 studi
- Atlanta, GA18 studi
- Chicago, IL18 studi
- Columbus, OH18 studi
- Dallas, TX17 studi
Altri studi a Salt Lake City
- Cancro del polmone non a piccole cellule31 studi
- Cancro (tutti i tipi)27 studi
- Cancro al seno27 studi
- Cancro colorettale22 studi
- Cancro ai polmoni21 studi
- Melanoma21 studi
- Mieloma multiplo21 studi
- Cancro metastatico20 studi
- Cancro ovarico19 studi
- Obesità18 studi
- Leucemia mieloide acuta17 studi
- Insufficienza cardiaca17 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.